Details

Autor(en) / Beteiligte

• Sukocheva, Olga A
• Neganova, Margarita E
• Aleksandrova, Yulia
• Burcher, Jack T
• Chugunova, Elena
• Fan, Ruitai
• Tse, Edmund
• Sethi, Gautam
• Bishayee, Anupam
• Liu, Junqi

Titel

Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-[alpha] immunotherapy

Ist Teil von

• Cell communication and signaling, 2024-05, Vol.22 (1)

Ort / Verlag

BioMed Central Ltd

Erscheinungsjahr

2024

Quelle

SpringerLink_现刊

Beschreibungen/Notizen

• Anticancer immune surveillance and immunotherapies trigger activation of cytotoxic cytokine signaling, including tumor necrosis factor-[alpha] (TNF-[alpha]) and TNF-related apoptosis-inducing ligand (TRAIL) pathways. The pro-inflammatory cytokine TNF-[alpha] may be secreted by stromal cells, tumor-associated macrophages, and by cancer cells, indicating a prominent role in the tumor microenvironment (TME). However, tumors manage to adapt, escape immune surveillance, and ultimately develop resistance to the cytotoxic effects of TNF-[alpha]. The mechanisms by which cancer cells evade host immunity is a central topic of current cancer research. Resistance to TNF-[alpha] is mediated by diverse molecular mechanisms, such as mutation or downregulation of TNF/TRAIL receptors, as well as activation of anti-apoptotic enzymes and transcription factors. TNF-[alpha] signaling is also mediated by sphingosine kinases (SphK1 and SphK2), which are responsible for synthesis of the growth-stimulating phospholipid, sphingosine-1-phosphate (S1P). Multiple studies have demonstrated the crucial role of S1P and its transmembrane receptors (S1PR) in both the regulation of inflammatory responses and progression of cancer. Considering that the SphK/S1P/S1PR axis mediates cancer resistance, this sphingolipid signaling pathway is of mechanistic significance when considering immunotherapy-resistant malignancies. However, the exact mechanism by which sphingolipids contribute to the evasion of immune surveillance and abrogation of TNF-[alpha]-induced apoptosis remains largely unclear. This study reviews mechanisms of TNF-[alpha]-resistance in cancer cells, with emphasis on the pro-survival and immunomodulatory effects of sphingolipids. Inhibition of SphK/S1P-linked pro-survival branch may facilitate reactivation of the pro-apoptotic TNF superfamily effects, although the role of SphK/S1P inhibitors in the regulation of the TME and lymphocyte trafficking should be thoroughly assessed in future studies.